Liability of Pharmaceutical Companies in Drug Quality Assurance
Tanggung Gugat Perusahaan Farmasi dalam Penjaminan Kualitas Obat
DOI:
https://doi.org/10.21070/ups.11477Keywords:
Pharmaceutical, Consumer protectionAbstract
Pharmaceutical companies play a very important role in ensuring the availability of safe, quality, and effective medicine for consumers. Medicine is one of the health products widely used by the public, so its production process needs to be very strict in terms of both storage and distribution. However, there are still many instances where medicines reach consumers in defective or damaged conditions, not meeting the Good Distribution Practices (GDP) standards. This situation is highly detrimental to consumers, both materially and immaterially, and it also leads to legal issues related to the liability of pharmaceutical companies. This research uses a normative method with an approach based on legislation. The study focuses on analyzing the legal norms that regulate the liability of pharmaceutical companiesfrom the perspectives of civil law, administrative law, and the concept of product liability.
Downloads
References
R. A. Cakrawibawa and K. Roisah, “THE CONSUMER PROTECTION ISSUES TOWARD THE TRADEMARK CIRCULATION OF THE COUNTERFEIT HEALTH PRODUCTS,” 2019. doi: https://ejournal.undip.ac.id/index.php/lawreform/article/view/23371/15144.
D. Bagus Anggito, “Pertanggungjawaban Negara dan Pelaku Usaha Farmasi dalam Kasus Gagal Ginjal Akut Indonesia,” vol. 6, no. 1, 2023, doi: 10.31933/unesrev.v6i1.
D. Djiwono, Y. A. Hasan, and A. H. Hamid, “TANGGUNG JAWAB HUKUM PENGELOLAAPOTEK ATAS PENJUALAN OBAT KERAS TANPA RESEP DOKTER DI KOTA MAKASSAR,” Indonesian Journal of Legality of Law, vol. 8, no. 1, pp. 77–83, Dec. 2025, doi: 10.35965/ijlf.v8i1.6658.
A. Sopian Sauri, Y. Rahmatiar, M. Abas, U. Buana, and P. Karawang, “ANALISIS PERLINDUNGAN
KONSUMEN TERHADAP TANGGUNG JAWAB PELAKU USAHA MEMPRODUKSI OBAT SIRUP CAIR YANG MENIMBULKAN GAGAL GINJAL AKUT PADA ANAK,” 2023. [Online]. Available: http://ejournal.stihawanglong.ac.id/index.php/juris
J. Surya and K. Dua, “TANGGUNG JAWAB PELAKU USAHA MEMPRODUKSI OBAT SIRUP CAIR MENIMBULKAN GAGAL GINJAL AKUT PADA ANAK,” 2022. [Online]. Available: https://kampus.republika.co.id:11/11/2022
C. Ciptawan, B. Ginting, S. Sunarmi, and M. Siregar, “Upaya Perlindungan Hukum Konsumen Terhadap Produk Yang Tidak Memenuhi Kewajiban Standar Nasional Indonesia,” Locus: Jurnal Konsep Ilmu Hukum, vol. 3, no. 1, pp. 21–34, Mar. 2023, doi: 10.56128/jkih.v3i1.39.
Rahmatiah HL, Tri Suhenra Arbani, and Rahmatul Akbar, “Strict Liability and Product Safety: The Case of Dangerous Syrup in Indonesia in the MAqāṣid Al-shArī’Ah Perspective,” vol. 23, pp. 543–562, 2023, Accessed: Feb.
, 2026. [Online]. Available: https://journal.uinjkt.ac.id/ahkam/article/view/34240/13475
Jessica Chelsea Defanthonieta and Ina Rosmaya, “TINJAUAN HUKUM PIDANA ATAS KELALAIAN BADAN PENGAWAS OBAT DAN MAKANAN TERKAIT PELANGGARAN HAK-HAK KONSUMEN DALAM KASUS PENARIKAN OBAT-OBATAN TERCEMAR,” Judiciary, vol. 13, no. 1, 2024, Accessed: Feb. 06, 2026. [Online]. Available: https://ejournal.fh.ubhara.ac.id/index.php/judiciary/article/view/236
M. Carmelia Manek and G. P. Soemartono, “Legal Liability of Business Actors for Prohibited Products: A Juridical
Review of the Consumer Protection Law and the Health Law,” Jurisprudensi: Jurnal Ilmu Syariah, PerundangUndangan dan Ekonomi Islam, vol. 17, no. 1, pp. 367–381, Jun. 2025, doi:
32505/jurisprudensi.v17i1.11539.
Audina Ayu Salsabilla, Sri Astutik, Muhammad Yustino Aribawa, and Fitri Ayuningtyas, “Tanggung Gugat Produk Pelaku Usaha Farmasi Berdasarkan Undang-Undang Perlindungan Konsumen,” Jurnal Kajian Hukum Dan Keadilan,pp. 440–472, 2025, Accessed: Feb. 06, 2026. [Online]. Available:13. https://ejournal.unitomo.ac.id/index.php/hukum/article/view/11014/5014
A. Salsabila et al., “TANGGUNG JAWAB HUKUM PRODUSEN OBAT TERHADAP EFEK SAMPING YANG MERUGIKAN (STUDI KASUS OBAT SYRUP ANAK),” 2025.
O. : Deddy, A. Yahanan, and I. Rumesten, “TANGGUNG JAWAB HUKUM PEDAGANG BESAR FARMASI TERHADAP DISTRIBUSI OBAT GENERIK KEPADA APOTEK,” Nov. 2025.
S. Johan and C. Rahayu, “Who is Liable for Medicine Containing Toxic Chemicals Based on The Consumer Protection Law,” vol. 22, no. 1, pp. 53–60, 2023.
Nanda Divabuena Purba and Amad Sudiro, “Tanggung Jawab Pihak Usaha atas Kerugian Konsumen dalam Kasus Obat Sirup Berbahaya berdasarkan Undang-Undang Nomor 8 Tahun 1999 tentang Perlindungan Konsumen,” Indonesian Journal of Law and Economics Review, vol. 4, pp. 6–14, Nov. 2025, Accessed: Feb. 06, 2026. [Online]. Available: https://ijler.umsida.ac.id/index.php/ijler/article/view/1339/1572
F. Al Ghiffariy and R. B. Setianingrum, “PROCEEDING LEGAL SYMPOSIUM Tanggung Jawab Hukum Perusahaan Atas Produk Cacat Dalam Perspektif Undang-Undang Perlindungan Konsumen,” vol. 3, no. 1, pp. 2987– 2634, 2025, doi: 10.18196/pls.v3i1.136.
H. Yusuf, D. Ahsani Awalia, N. Fhadyah Azzahra, I. Zulfah Sabilla, and C. Adam Sitorus, “Al-Dalil Perlindungan Konsumen Atas Obat Sirup Pemicu Gagal Ginjal Akut,” vol. 3, no. 1, 2025, [Online]. Available: https://ejournal.indrainstitute.id/index.php/al-dalil/index
A. Sopian Sauri, Y. Rahmatiar, M. Abas, U. Buana, and P. Karawang, “ANALISIS PERLINDUNGAN
KONSUMEN TERHADAP TANGGUNG JAWAB PELAKU USAHA MEMPRODUKSI OBAT SIRUP CAIR YANG MENIMBULKAN GAGAL GINJAL AKUT PADA ANAK,” 2023. [Online]. Available: http://ejournal.stihawanglong.ac.id/index.php/juris
L. S. Muis, R. Jened, N. Barizah, and G. C. Tjwan, “State Responsibility for Access and Availability of Patented Drugs for Public Health,” Yuridika, vol. 38, no. 2, pp. 219–242, May 2023, doi: 10.20473/ydk.v38i2.43007.
K. A. Aryawati and L. Ubaidillah, “Tanggung Gugat Perusahaan Farmasi Terhadap Konsumen Mengkonsumsi Obat Sirup Yang Mengandung Etilen Glikol Dan Dietilen Glikol (Kasus Gagal Ginjal Akut Pada Anak),” Indonesian Journal of Law and Justice, vol. 1, no. 4, p. 8, Jul. 2024, doi: 10.47134/ijlj.v1i4.2911.
M. Carmelia Manek and G. P. Soemartono, “Legal Liability of Business Actors for Prohibited Products: A Juridical
Review of the Consumer Protection Law and the Health Law,” Jurisprudensi: Jurnal Ilmu Syariah, PerundangUndangan dan Ekonomi Islam, vol. 17, no. 1, pp. 367–381, Jun. 2025, doi:
32505/jurisprudensi.v17i1.11539.
Fadli Hamdi and Robi Syafwar, “Pertanggungjawaban BPOM Dan Perusahaan Farmasi Dalam Penggunaan Obat
Syrup Anak yang Terkontaminasi Bahan Kimia Berbahaya,” Jurnal Kajian Hukum Dan Kebijakan Publik, vol. 2, pp.
–417, Jul. 2024, Accessed: Feb. 06, 2026. [Online]. Available: 10. https://jurnal.kopusindo.com/index.php/jkhkp/article/view/397/414
C. A. Siswanto, A. A. Indradewi, K. X. Emmanuella Pallo, and A. Z. Purba, “Perlindungan Konsumen Terhadap Pembelian Obat Mengandung Psikotropika Pada Online Marketplace,” JURNAL USM LAW REVIEW, vol. 5, no. 2, pp. 553–568, Oct. 2022, doi: 10.26623/julr.v5i2.5337.
C. Ciptawan, B. Ginting, S. Sunarmi, and M. Siregar, “Upaya Perlindungan Hukum Konsumen Terhadap Produk Yang Tidak Memenuhi Kewajiban Standar Nasional Indonesia,” Locus: Jurnal Konsep Ilmu Hukum, vol. 3, no. 1, pp. 21–34, Mar. 2023, doi: 10.56128/jkih.v3i1.39.
Raihan Muhammad Tharif and Diana Wiyanti, “Tanggung Jawab Produsen Obat yang Mengakibatkan Gagal Ginjal Akut pada Anak,” Jurnal Riset Ilmu Hukum, vol. 4, no. 1, pp. 9–16, Jul. 2024, doi: 10.29313/jrih.v4i1.3749.
L. S. Muis, R. Jened, N. Barizah, and G. C. Tjwan, “State Responsibility for Access and Availability of Patented Drugs for Public Health,” Yuridika, vol. 38, no. 2, pp. 219–242, May 2023, doi: 10.20473/ydk.v38i2.43007.
Downloads
Additional Files
Posted
Categories
License
Copyright (c) 2026 UMSIDA Preprints Server
This work is licensed under a Creative Commons Attribution 4.0 International License.
